ArticleCell reports2025

Heterozygous Kmt2d loss diminishes enhancers to render medulloblastoma cells vulnerable to combinatory inhibition of LSD1 and OXPHOS.

Shilpa S Dhar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.